Market Cap | ₹47Cr |
ROE | 3.69% |
P/E Ratio(TTM) | 30.30 |
EPS(TTM) | 1.61 |
P/B Ratio | 1.12 |
Dividend Yield | 0.00% |
Industry P/E | 35.21 |
Book Value | 43.50 |
Debt to Equity | 0.01 |
Face Value | 10 |
Parent Organisation | Sandu Pharmaceuticals Limited |
Managing Director | Shri. Umesh Sandu |
BSE Symbol | 524703 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Torrent Pharmaceuticals | NA (0.00%) | 59.90 | ||
Gland Pharma | NA (0.00%) | 42.52 | ||
Ajanta Pharma | NA (0.00%) | 34.41 | ||
Eris Lifesciences | NA (0.00%) | 57.97 |